146 related articles for article (PubMed ID: 8339398)
1. Low doses of scopolamine increase cardiac vagal tone in the acute phase of myocardial infarction.
Casadei B; Pipilis A; Sessa F; Conway J; Sleight P
Circulation; 1993 Aug; 88(2):353-7. PubMed ID: 8339398
[TBL] [Abstract][Full Text] [Related]
2. Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction.
De Ferrari GM; Mantica M; Vanoli E; Hull SS; Schwartz PJ
J Am Coll Cardiol; 1993 Nov; 22(5):1327-34. PubMed ID: 8227788
[TBL] [Abstract][Full Text] [Related]
3. Low dose transdermal scopolamine increases cardiac vagal tone in patients after acute myocardial infarction.
Wang L; Wang L; Zhang Y; Zhang B; Chen M
Chin Med J (Engl); 2002 May; 115(5):770-2. PubMed ID: 12133554
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction.
Pedretti RF; Colombo E; Sarzi Braga S; Ballardini L; Carù B
J Am Coll Cardiol; 1995 Mar; 25(4):915-21. PubMed ID: 7884097
[TBL] [Abstract][Full Text] [Related]
5. The long-term increase of baseline and reflexly augmented levels of human vagal-cardiac nervous activity induced by scopolamine.
Dibner-Dunlap ME; Eckberg DL; Magid NM; Cintrón-Treviño NM
Circulation; 1985 Apr; 71(4):797-804. PubMed ID: 3971545
[TBL] [Abstract][Full Text] [Related]
6. Influence of transdermal scopolamine on cardiac sympathovagal interaction after acute myocardial infarction.
Pedretti R; Colombo E; Sarzi Braga S; Carù B
Am J Cardiol; 1993 Aug; 72(5):384-92. PubMed ID: 8352179
[TBL] [Abstract][Full Text] [Related]
7. Scopolamine improves autonomic balance in advanced congestive heart failure.
La Rovere MT; Mortara A; Pantaleo P; Maestri R; Cobelli F; Tavazzi L
Circulation; 1994 Aug; 90(2):838-43. PubMed ID: 8044956
[TBL] [Abstract][Full Text] [Related]
8. Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure.
Casadei B; Conway J; Forfar C; Sleight P
Heart; 1996 Mar; 75(3):274-80. PubMed ID: 8800992
[TBL] [Abstract][Full Text] [Related]
9. Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine.
Hull SS; Vanoli E; Adamson PB; De Ferrari GM; Foreman RD; Schwartz PJ
Circulation; 1995 May; 91(10):2516-9. PubMed ID: 7743612
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of captopril administration on baroreflex sensitivity in patients with acute myocardial infarction.
Marakas SA; Kyriakidis MK; Vourlioti AN; Petropoulakis PN; Toutouzas PK
Eur Heart J; 1995 Jul; 16(7):914-21. PubMed ID: 7498206
[TBL] [Abstract][Full Text] [Related]
11. Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death.
Cerati D; Schwartz PJ
Circ Res; 1991 Nov; 69(5):1389-401. PubMed ID: 1934362
[TBL] [Abstract][Full Text] [Related]
12. Low-dose transdermal scopolamine decreases blood pressure in mild essential hypertension.
Vesalainen RK; Kaila TJ; Kantola IM; Tahvanainen KU; Juhani Airaksinen KE; Kuusela TA; Eckberg DL
J Hypertens; 1998 Mar; 16(3):321-9. PubMed ID: 9557925
[TBL] [Abstract][Full Text] [Related]
13. Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure.
Venkatesh G; Fallen EL; Kamath MV; Connolly S; Yusuf S
Heart; 1996 Aug; 76(2):137-43. PubMed ID: 8795476
[TBL] [Abstract][Full Text] [Related]
14. Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction.
Bonaduce D; Marciano F; Petretta M; Migaux ML; Morgano G; Bianchi V; Salemme L; Valva G; Condorelli M
Circulation; 1994 Jul; 90(1):108-13. PubMed ID: 8025984
[TBL] [Abstract][Full Text] [Related]
15. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.
La Rovere MT; Bigger JT; Marcus FI; Mortara A; Schwartz PJ
Lancet; 1998 Feb; 351(9101):478-84. PubMed ID: 9482439
[TBL] [Abstract][Full Text] [Related]
16. Reflex versus tonic vagal activity as a prognostic parameter in patients with sustained ventricular tachycardia or ventricular fibrillation.
Hohnloser SH; Klingenheben T; van de Loo A; Hablawetz E; Just H; Schwartz PJ
Circulation; 1994 Mar; 89(3):1068-73. PubMed ID: 8124792
[TBL] [Abstract][Full Text] [Related]
17. Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction.
Vybiral T; Glaeser DH; Morris G; Hess KR; Yang K; Francis M; Pratt CM
J Am Coll Cardiol; 1993 Nov; 22(5):1320-6. PubMed ID: 8227787
[TBL] [Abstract][Full Text] [Related]
18. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification.
Schwartz PJ; La Rovere MT; Vanoli E
Circulation; 1992 Jan; 85(1 Suppl):I77-91. PubMed ID: 1728509
[TBL] [Abstract][Full Text] [Related]
19. Baroreflex sensitivity and electrophysiological correlates in patients after acute myocardial infarction.
Farrell TG; Paul V; Cripps TR; Malik M; Bennett ED; Ward D; Camm AJ
Circulation; 1991 Mar; 83(3):945-52. PubMed ID: 1999042
[TBL] [Abstract][Full Text] [Related]
20. Baroreflex and non-baroreflex modulation of vagal cardiac control after myocardial infarction.
Grassi G; Seravalle G; Giannattasio C; Saino A; Turri C; Mancia G
Am J Cardiol; 1999 Sep; 84(5):525-9. PubMed ID: 10482149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
